Pharmacology, Toxicology and Pharmaceutical Science
Artemisinin
95%
Antimalarial Agent
88%
Plasmodium falciparum
59%
Proteasome
52%
Combination Therapy
40%
SARS Coronavirus
34%
Plasmodium
31%
Drug Resistance
20%
Proteasome Inhibitor
18%
Plasmodium vivax
17%
Repurposing
17%
Dihydroorotate Dehydrogenase Inhibitor
17%
Hemoprotein
17%
Piperazine
17%
Disease
15%
Elimination
14%
Ubiquitin
10%
Artemisinin Derivative
10%
Malaria Falciparum
9%
Ubiquitin C
8%
Parasite Clearance
8%
Rodent Malaria
8%
Quinoline Derivative
8%
Atovaquone
8%
Proteinase
6%
Mefloquine
5%
Plasmodium Vivax Malaria
5%
Benflumetol
5%
Amodiaquine
5%
ABC Transporter
5%
Sulfone
5%
Coronavirinae
5%
Keyphrases
UCHL3
17%
Covalent Fragments
17%
Resistance Genes
17%
Uncomplicated Plasmodium Falciparum
17%
Network Compression
17%
EXP1
17%
Plasmodium Falciparum
17%
Benzoxaborole
17%
First-in-human
17%
US11
17%
Immuno-epidemiology
17%
Asexual Blood Stages
17%
Pfmdr1
17%
In Vitro Resistance
17%
Resistance Selection
17%
Artemisinin Antimalarial
17%
Dihydroorotate Dehydrogenase Inhibitor
17%
DSM265
17%
Hexahydroquinoline
17%
Gene Editing
17%
Antimalarial Drugs
17%
Parasite Susceptibility
13%
Capture Method
11%
Plasmodium Vivax
10%
Site-directed
8%
Ring Stage
8%
Antimalarial Resistance
8%
Ring-stage Survival Assay
8%
Over 40
8%
Epoxyketone
8%
Genetic Changes
8%
Macrocyclic Peptides
8%
Artemisinin Drugs
8%
Malaria Cases
8%
In Vitro Selection
8%
Schizont
8%
Machine Learning-based Approach
8%
Automated Clustering
8%
Human Malaria
8%
Compound Mode
8%
Drug-resistant Parasites
8%
Global Health Burden
8%
Drug Resistance
8%
Etiological Agents
8%
Resistant Malaria
8%
Malaria
8%
Electrophilic Warhead
8%
Co-inhibition
8%
World Population
8%
Liver Stage
6%
Immunology and Microbiology
Antimalarial Agent
100%
Plasmodium falciparum
91%
Proteasome
43%
Plasmodium
33%
Gene Editing
26%
CRISPR/Cas9
21%
Intravenous Immunoglobulin
17%
Drug Resistance
17%
Plasmodium vivax
17%
Bacillus Subtilis
17%
Multidrug Resistance Protein 1
17%
Gametocyte
17%
COVID-19
17%
Severe Acute Respiratory Syndrome Coronavirus 2
17%
Solution and Solubility
17%
Solubilization
11%
Human Cell
8%
Multidrug Resistance
8%
Sporozoite
8%
ED90
8%
in Vitro Selection
8%
Gene Mutation
8%
Gamete
8%
Schizont
8%
Mediator
8%
Atovaquone
8%
Carboxy Terminal Sequence
8%
Antiporter
5%
Protein Processing
5%
Size Exclusion Chromatography
5%
Inner Membrane
5%
Western Blot
5%
Escherichia coli
5%
Protein Degradation
5%
